Multicenter expert recommendations on interventional valve-in-valve technology for mitral bioprosthetic valve destruction in China
- VernacularTitle:中国心脏二尖瓣生物瓣毁损介入瓣中瓣技术多中心专家建议
- Author:
Haibo ZHANG
1
;
Xiangbin PAN
2
;
Yingqiang GUO
3
;
Lai WEI
4
;
Jian YANG
5
,
6
;
Daxin ZHOU
7
;
Yongjian WU
8
;
Xu MENG
1
;
Liming LIU
9
Author Information
1. Valve Surgery Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P. R. China
2. Structural Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P. R. China
3. Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, 610041, P. R. China
4. Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China
5. Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'
6. an, 710032, P. R. China
7. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China
8. Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China
9. The Second Xiangya Hospital of Central South University, Changsha, 410011, P. R. China
- Collective Name:Chinese Research Hospital Association (CRHA) Heart Valve Disease Professional Committee, Asian Association for Heart Valve Disease (AAHVD) China Chapter
- Publication Type:Journal Article
- Keywords:
Mitral bioprosthetic valve destruction;
interventional valve-in-valve;
expert recommendations
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(08):1090-1095
- CountryChina
- Language:Chinese
-
Abstract:
Mitral valve replacement is one of the most common heart valve surgeries in China. In recent years, with the increase in degenerative valve diseases, older patients, and the progress of anti-calcification technology of biological valves, the proportion of mitral valve biological valve replacement has been increasing year by year. After the damage of traditional mitral valve biological valves, re-operation of valve replacement with thoracotomy is required. However, the adhesion between the heart and sternum, as well as the damage caused by cardiopulmonary bypass and cardiac arrest, can cause significant trauma to elderly patients and those with multiple organ dysfunction, leading to increased mortality and complication rates. In recent years, interventional valve surgery, especially transcatheter valve-in-valve surgery, has developed rapidly. This procedure can correct the damaged mitral valve function without stopping the heart, but there are still many differences between its technical process and conventional aortic valve replacement surgery. Therefore, organizing and writing multicenter expert recommendations on the technical process of transcatheter valve-in-valve surgery for damaged mitral valve biological valves is of great significance for the training and promotion of this technology.
